Inventor

TAVERNIER JAN

BE70 patents

⚠️ This page may combine multiple inventors who share the name “TAVERNIER JAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TAVERNIER JAN

VIB VZW

Fusokines involving cytokines with strongly reduced receptor binding affinities

Targeted modified TNF family members

Targeting of human interferon antagonists

Targeted modified TNF family members

Targeted modified TNF family members

Targeting of human interferon antagonists

Targeted human-interferon fusion proteins

Targeted human-interferon fusion proteins

Targeted human-interferon fusion proteins

Targeted modified IL-1 family members

Immune-cell targeted bispecific chimeric proteins and uses thereof

Methods of inhibiting leptin-induced signaling with fibronectin III domain antibodies

Targeting of human interferon antagonists

Targeted modified TNF family members

Targeted and mutated human-interferon fusion proteins

Fusokines involving cytokines with strongly reduced receptor binding affinities

CD20 binding single domain antibodies

Targeted modified TNF family members

Targeted modified TNF family members

Method for detecting protein-protein interactions in a cell utilizing particle-forming polypeptide-bait fusion proteins and virus-like particles

ORIONIS BIOSCIENCES INC

Targeted engineered interferon and uses thereof

Therapeutic interferon alpha 1 proteins

Targeted engineered interferon and uses thereof

Therapeutic interferon alpha 1 proteins

Fibroblast binding agents and use thereof

CD8 binding agents

Modulation of dendritic cell lineages

PD-1 and PD-L1 binding agents

CLEC9A-based chimeric protein complexes

Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH)

SIRP1α targeted chimeric proteins and uses thereof

Fibroblast binding agents and use thereof

CD8 binding agents

PD-1 and PD-L1 binding agents

Orionis Biosciences BV

Clec9A binding agents

Targeted mutant interferon-beta and uses thereof

CD8 binding agents

Bispecific signaling agents and uses thereof

Chimeric protein comprising an interferon alpha 2mutant and a PD-L1 binding moiety

Targeted chimeric proteins and uses thereof

Therapeutic targeting of non-cellular structures

Targeted mutant interferon-gamma and uses thereof

Chimeric protein, and encoding nucleic acid thereof, comprising interferon-β and a targeting moiety comprising a single-domain antibody or single-chain antibody

HOFFMANN LA ROCHE

TNF-muteins

Chimeric interleukin 5-receptor/immunoglobulin polypeptides

DNAs encoding tumor necrosis factor-α muteins

Chimeric interleukin 5-receptor/immunoglobulin polypeptides

DNA encoding chimeric polypeptides comprising the interleukin-5 receptor α-chain fused to immunoglobulin heavy chain constant regions

ORIONIS BIOSCIENCES NV

Targeted mutant interferon-gamma and uses thereof

VLAAMS INTERUNIV INST BIOTECH

Leptin-mediated gene-induction